Preoperative treatment and surgery in gastric cancer: friends or foes?

The Lancet Oncology

Volumn 10, Issue 2, 2009, Pages 191-195

  D'Ugo, Domenico ^a   Rausei, Stefano ^a   Biondi, Alberto ^a   Persiani, Roberto ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

5 CHLORO 2,4 DIHYDROXYPYRIDINE PLUS OXONATE POTASSIUM PLUS TEGAFUR; ANTINEOPLASTIC AGENT; BEVACIZUMAB; CAPECITABINE; CISPLATIN; DOXORUBICIN; EPIRUBICIN; ETOPOSIDE; FLOXURIDINE; FLUOROURACIL; FOLINIC ACID; METHOTREXATE;

ARTICLE; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL TRIAL; DRUG EFFICACY; GASTRECTOMY; HUMAN; LAPAROTOMY; PATIENT SELECTION; PERIOPERATIVE PERIOD; POSTOPERATIVE CARE; PREOPERATIVE RADIOTHERAPY; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; STOMACH CANCER; STOMACH CARCINOMA; STOMACH SURGERY; SURGICAL MORTALITY; THERAPY DELAY; TREATMENT OUTCOME;

EID: 58949091998     PISSN: 14702045     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1470-2045(09)70021-X     Document Type: Note

References (38)

1. Fujimoto S., Akao T., Itoh B., Koshizuka I., and Koyano K. A study of survival in patients with stomach cancer treated by a combination of preoperative intra-arterial infusion therapy and surgery. Cancer 37 (1976) 1648-1653
2. Bonatsos C., Aust J., Meisner D., Poisez B., and Comis R. Preoperative chemotherapy for patients with locally advanced gastric carcinoma. Proc ASCO 4 (1985) 83
3. Stephens F.O., Adams B.G., and Crea P. Intra-arterial chemotherapy given preoperatively in the management of carcinoma of the stomach. Surg Gynecol Obstet 162 (1986) 370-374
4. Cunningham D., Allum W.H., Stenning S.P., et al. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med 355 (2006) 11-20
5. Boige V., Pignon J., Saint-Aubert B., et al. Final results of a randomized trial comparing preoperative 5-fluorouracil (F)/cisplatin (P) to surgery alone in adenocarcinoma of stomach and lower esophagus (ASLE): FNLCC ACCORD07-FFCD 9703 trial. J Clin Oncol 25 (2007) 4510
6. Fisher B., Gunduz N., and Coyle J. Presence of a growth stimulating factor in serum following primary tumor removal in mice. Cancer Res 49 (1989) 1996-2001
7. Fink U., Stein H.J., Schuhmacher C., and Wilke H.J. Neoadjuvant chemotherapy for gastric cancer: update. World J Surg 19 (1995) 509-516
8. Bozzetti F., Gianotti L., Braga M., Di Carlo V., and Mariani L. Postoperative complications in gastrointestinal cancer patients: the joint role of the nutritional status and the nutritional support. Clin Nutr 26 (2007) 698-709
9. Wilke H., Preusser P., Fink U., et al. Preoperative chemotherapy in locally advanced and nonresectable gastric cancer: a phase II study with etoposide, doxorubicin and cisplatin. J Clin Oncol 7 (1989) 1318-1326
10. Plukker J.T., Mulder N.H., Sleijfer D.T.H., Grond J., and Verschueren R.J.C. Chemotherapy and surgery for locally advanced cancer of the cardia and fundus: phase II study with methotrexate and 5-fluorouracil. Br J Surg 78 (1991) 955-958
11. Ajani J.A., Ota D.M., Jessup M., et al. Resectable gastric carcinoma: an evaluation of preoperative and postoperative chemotherapy. Cancer 68 (1991) 1501-1506
12. Leichman L., Silberman H., Leichman C.G., et al. Preoperative systemic chemotherapy followed by adjuvant postoperative intraperitoneal therapy for gastric cancer: a University of Southern California pilot program. J Clin Oncol 10 (1992) 1933-1942
13. Leichman L., Silberman H., Leichman C.G., Laine L., Kiyabu R., and Stain S. Intravenous neoadjuvant chemotherapy for operable gastric cancer patients followed by intraperitoneal therapy after successful resection. In: Salmon S.E. (Ed). Adjuvant therapy of cancer. seventh edn (1993), Lippincott, Philadelphia 261-271
14. Kang Y.K., Choi D.W., Kim C.W., Lee J.I., Hong W.S., and Paik N.S. The effect of neoadjuvant chemotherapy on the surgical outcome of locally advanced gastric adenocarcinoma: interim report of a randomized controlled trial. Proc ASCO 11 (1992) 173
15. Ajani J.A., Mayer R.J., Ota D.M., et al. Preoperative and postoperative chemotherapy for patients with potentially resectable gastric carcinoma. J Natl Cancer Inst 85 (1993) 1839-1844
16. Rougier P., Lasser P., Ducreux M., Mahjoubi M., Bognel C., and Elias D. Preoperative chemotherapy of locally advanced gastric cancer. Ann Oncol 5 (1994) 59-68
17. Kelsen D. Neoadjuvant therapy for gastrointestinal cancers. Oncology (Williston Park) 7 (1993) 25-32
18. Kelsen D., Karpeh M., Schwartz G., et al. Neoadjuvant therapy of high-risk gastric cancer: a phase II trial of preoperative FAMTX and postoperative intraperitoneal fluorouracil-cisplatin plus intravenous fluorouracil. J Clin Oncol 14 (1996) 1818-1828
19. Crookes P., Leichman C.G., Leichman L., et al. Systemic chemotherapy for gastric carcinoma followed by postoperative intraperitoneal therapy: a final report. Cancer 79 (1997) 1767-1775
20. Songun I., Keizer H.J., Hermans J., et al. Chemotherapy for operable gastric cancer: results of the Dutch randomised FAMTX trial. Eur J Cancer 35 (1999) 558-562
21. Schuhmacher C.P., Fink U., Becker K., et al. Neoadjuvant therapy for patients with locally advanced gastric carcinoma with etoposide, doxorubicin, and cisplatinum: closing results after 5 years of follow-up. Cancer 91 (2001) 918-927
22. Persiani R., D'Ugo D., Rausei S., et al. Prognostic indicators in locally advanced gastric cancer (LAGC) treated with preoperative chemotherapy and D2-gastrectomy. J Surg Oncol 89 (2005) 227-236
23. Hartgrink H.H., van de Velde C.J., Putter H., et al. Neo-adjuvant chemotherapy for operable gastric cancer: long term results of the Dutch randomised FAMTX trial. Eur J Surg Oncol 30 (2004) 643-649
24. Barone C., Cassano A., Pozzo C., et al. Long-term follow-up of a pilot phase II study with neoadjuvant epidoxorubicin, etoposide and cisplatin in gastric cancer. Oncology 67 (2004) 48-53
25. D'Ugo D., Persiani R., Rausei S., et al. Response to neoadjuvant chemotherapy and effects of tumor regression in gastric cancer. Eur J Surg Oncol 32 (2006) 1105-1109
26. Briasoulis E., Fatouros M., and Roukos D.H. Level I evidence in support of perioperative chemotherapy for operable gastric cancer: sufficient for wide clinical use?. Ann Surg Oncol 14 (2007) 2691-2695
27. Lim L., Michael M., Mann G.B., and Leong T. Adjuvant therapy in gastric cancer. J Clin Oncol 23 (2005) 6220-6232
28. Sakuramoto S., Sasako M., Yamaguchi T., et al. Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine. New Engl J Med 357 (2007) 1810-1820
29. Dutch Colorectal Cancer Group. Randomized phase III trial of adjuvant chemotherapy or chemoradiotherapy in resectable gastric cancer (CRITICS). http://clinicaltrials.gov/ct2/show/NCT00407186?term=CRITICS+trial&ra nk=1 (accessed Dec 19, 2008).
30. Sanofi-Aventis (Medical Affairs Study Director). Capecitabine and oxaliplatin adjuvant study in stomach cancer (CLASSIC). http://clinicaltrial.gov/ct2/show/NCT00411229?term=CLASSIC+gastric+cance r&rank=2 (accessed Dec 19, 2008).
31. Samsung Medical Center. Phase III Randomized trial of adjuvant XP chemotherapy and XP/RT for resected gastric adenocarcinoma. http://clinicaltrial.gov/ct2/show/NCT00323830?term=SMC+IRB2004-08-10 &rank=1 (accessed Dec 19, 2008).
32. Macdonald J.S., Smalley S.R., Benedetti J., et al. Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. N Engl J Med 345 (2001) 725-730
33. Zhang Z.X., Gu X.Z., Yin W.B., et al. Randomized clinical trial of the combination of preoperative irradiation and surgery in the treatment of adenocarcinoma of the gastric cardia (AGC)-report on 370 patients. Int J Radiat Oncol Biol Phys 42 (1998) 929-934
34. Xiong H.Q., Gunderson L.L., Yao J., and Ajani J.A. Chemoradiation for resectable gastric cancer. Lancet Oncol 4 (2003) 498-505
35. Ajani J.A., Mansfield P.F., Janjan N., et al. Multi-institutional trial of preoperative chemoradiotherapy in patients with potentially resectable gastric carcinoma. J Clin Oncol 22 (2004) 2774-2780
36. Fujitani K., Ajani J.A., Crane C.H., et al. Impact of induction chemotherapy and preoperative chemoradiotherapy on operative morbidity and mortality in patients with locoregional adenocarcinoma of the stomach or gastroesophageal junction. Ann Surg Oncol 14 (2007) 2010-2017
37. Medical Research Council. Combination chemotherapy with or without bevacizumab in treating patients with previously untreated stomach cancer or gastroesophageal junction cancer that can be removed by surgery. http://clinicaltrial.gov/ct2/show/NCT00450203?term=ST03+trial&rank=2 (accessed Dec 19, 2008).
38. Japan Clinical Oncology Group. A trial of neoadjuvant TS-1 and cisplatin for type 4 and large type 3 gastric cancer. http://clinicaltrial.gov/ct2/show/NCT00252161?term=JCOG+trial+0501&r ank=1 (accessed Dec 19, 2008).